Table 2.

Ten basic principles for optimizing the diagnostic yield of noninvasive diagnostic tests for patients with hematological malignancies and ARF

Do not perform all tests in every patient. Instead, rely on the pretest probability (DIRECT approach) to select tests with either high sensitivity for confirming a strongly suspected diagnosis or high negative predictive value for ruling out a diagnosis that has a low pretest probability. 
Identify the diagnosis. Every patient must have a diagnostic workup, which may involve a single diagnostic test when the diagnosis is obvious (echocardiography, pleural drainage, and sputum test). 
Avoid cognitive bias. Do not be satisfied with a high pretest probability. Document the diagnosis using rapid diagnostic tests or invasive tests. Consider every possible differential diagnosis. 
In patients with hypoxemic ARF, give priority to noninvasive diagnostic tests. When a diagnosis can be made noninvasively, do not perform bronchoscopic-bronchoalveolar lavage 
Do not confuse a positive test with a diagnostic test. PCR can detect tiny amounts of viral DNA, whose presence does not confirm pneumonia due to the corresponding virus. Identified pathogens may be commensals or colonizing pathogens. 
A negative test can contribute substantially to the diagnosis. For a diagnosis with a low pretest probability, a test with a high negative predictive value can allow withdrawal of a treatment, thereby decreasing toxicity and cost. 
The best diagnostic test assesses the lung compartment predominantly affected by the disease. The diagnostic yield of bronchoscopic-bronchoalveolar lavage is high in patients with ground-glass opacities. These opacities indicate bronchoscopic-bronchoalveolar lavage, unless the patient is considered too unstable or too hypoxemic or a noninvasive diagnostic test can achieve the same diagnostic yield. 
When bronchoscopic-bronchoalveolar lavage is deemed mandatory for a patient with severe hypoxemia, early intubation that allows for the investigation is acceptable. Early intubation is an option when the patient is responding poorly, to avoid delaying necessary bronchoscopic-bronchoalveolar lavage. In these patients who are severely ill, the adverse effect on outcomes of failure to identify the cause of ARF deserves close consideration. 
The risk-to-benefit ratio of each procedure must be established by consensus. All alternatives and innovative options should be considered. 
Diagnostic strategies can be more effective than diagnostic tests. Integrating clinical data with a series of efficient tests can substantially increase diagnostic yields. 
Do not perform all tests in every patient. Instead, rely on the pretest probability (DIRECT approach) to select tests with either high sensitivity for confirming a strongly suspected diagnosis or high negative predictive value for ruling out a diagnosis that has a low pretest probability. 
Identify the diagnosis. Every patient must have a diagnostic workup, which may involve a single diagnostic test when the diagnosis is obvious (echocardiography, pleural drainage, and sputum test). 
Avoid cognitive bias. Do not be satisfied with a high pretest probability. Document the diagnosis using rapid diagnostic tests or invasive tests. Consider every possible differential diagnosis. 
In patients with hypoxemic ARF, give priority to noninvasive diagnostic tests. When a diagnosis can be made noninvasively, do not perform bronchoscopic-bronchoalveolar lavage 
Do not confuse a positive test with a diagnostic test. PCR can detect tiny amounts of viral DNA, whose presence does not confirm pneumonia due to the corresponding virus. Identified pathogens may be commensals or colonizing pathogens. 
A negative test can contribute substantially to the diagnosis. For a diagnosis with a low pretest probability, a test with a high negative predictive value can allow withdrawal of a treatment, thereby decreasing toxicity and cost. 
The best diagnostic test assesses the lung compartment predominantly affected by the disease. The diagnostic yield of bronchoscopic-bronchoalveolar lavage is high in patients with ground-glass opacities. These opacities indicate bronchoscopic-bronchoalveolar lavage, unless the patient is considered too unstable or too hypoxemic or a noninvasive diagnostic test can achieve the same diagnostic yield. 
When bronchoscopic-bronchoalveolar lavage is deemed mandatory for a patient with severe hypoxemia, early intubation that allows for the investigation is acceptable. Early intubation is an option when the patient is responding poorly, to avoid delaying necessary bronchoscopic-bronchoalveolar lavage. In these patients who are severely ill, the adverse effect on outcomes of failure to identify the cause of ARF deserves close consideration. 
The risk-to-benefit ratio of each procedure must be established by consensus. All alternatives and innovative options should be considered. 
Diagnostic strategies can be more effective than diagnostic tests. Integrating clinical data with a series of efficient tests can substantially increase diagnostic yields. 

or Create an Account

Close Modal
Close Modal